YM BioSciences (YMI) Narrows Q2 Loss; Revs Lighter

YM BioSciences (NYSE: YMI) reported Q2 EPS of (C$0.06), versus (C$0.14) reported last year. Revenue for the quarter came in at C$380.1 thousand, versus C$521.42 thousand reported last year.

For earnings history and earnings-related data on YM BioSciences (YMI) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Best Buy (BBY) Tops Q2 EPS by 12c, Offers Guidance
• Enbridge forms C$2.7B joint venture with KKR and Apollo
• Build-A-Bear Workshop (BBW) Tops Q2 EPS by 3c, Misses on Revenue; Offers FY Guidance